1-8 of 8
Marleen M. van Loenen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Allo-HLA reactivity of virus-specific memory T cells is common

Avital L. Amir, Lloyd J. A. D'Orsogna, Dave L. Roelen, Marleen M. van Loenen, Renate S. Hagedoorn, Renate de Boer, Menno A. W. G. van der Hoorn, Michel G. D. Kester, Ilias I. N. Doxiadis, J. H. Frederik Falkenburg, Frans H. J. Claas, Mirjam H. M. Heemskerk
Journal: Blood
Blood (2010) 115 (15): 3146–3157.
https://doi.org/10.1182/blood-2009-07-234906
Published: 2010
Journal Articles

Extracellular Domains of CD8a and β Subunits Are Required and Sufficient for HLA Class I Restricted Helper Activity of TCR-Engineered CD4 + T Cells.

Marleen M van Loenen, MSc, Renate S. Hagedoorn, MSc, Roelof Willemze, MD, PhD, J.H. Frederik Falkenburg, MD, PhD, Mirjam H.M. Heemskerk, PhD
Journal: Blood
Blood (2009) 114 (22): 3574.
https://doi.org/10.1182/blood.V114.22.3574.3574
Published: 2009
Journal Articles

Optimization of the HA-1-Specific T Cell Receptor for Gene Therapy of Hematological Malignancies.

Marleen M van Loenen, MSc, Renate S. Hagedoorn, MSc, Renate de Boer, BSc, Esther M. van Egmond, BSc, Roelof Willemze, MD, PhD, J.H. Frederik Falkenburg, MD, PhD, Mirjam H.M. Heemskerk, PhD
Journal: Blood
Blood (2009) 114 (22): 4093.
https://doi.org/10.1182/blood.V114.22.4093.4093
Published: 2009
Journal Articles

Recombination of Endogenous TCR Chains with Retrovirally Introduced TCR Chains Can Result in Mixed T Cell Receptor Dimers Harbouring Harmful Alloreactivity

Marleen M Van Loenen, MSc, Renate de Boer, BSc, Gerdien L Volbeda, BSc, Avital L Amir, MD, Renate S. Hagedoorn, MSc, Roelof Willemze, MD, PhD, J.H. Frederik Falkenburg, MD, PhD, Mirjam H.M. Heemskerk, PhD
Journal: Blood
Blood (2008) 112 (11): 823.
https://doi.org/10.1182/blood.V112.11.823.823
Published: 2008
Journal Articles

Alloreactivity of Virus Specific T-Cells.

Avital L. Amir, MD, Lloyd J.A. D’Orsogna, MD, Marleen M. van Loenen, MSC, Dave L. Roelen, PhD, Ilias I.N. Doxiadis, PhD, Frans H.J. Claas, PhD, J.H. Frederik Falkenburg, MD, PhD, Mirjam H.M. Heemskerk, PhD
Journal: Blood
Blood (2008) 112 (11): 3249.
https://doi.org/10.1182/blood.V112.11.3249.3249
Published: 2008
Journal Articles

Vigorous Priming of Minor Histocompatibility Antigen Specific T Cells by Frequent High Dose Peptide Vaccination May Lead to Prolonged T Cell Receptor Downregulation, Impaired T Cell Functionality, and Promotion of Tumor Escape.

Inge Jedema, Linda van Dreunen, Marleen M. van Loenen, Mirjam Heemskerk, Roel Willemze, J.H. Frederik Falkenburg
Journal: Blood
Blood (2007) 110 (11): 1809.
https://doi.org/10.1182/blood.V110.11.1809.1809
Published: 2007
Journal Articles

Physiological TCR Modulation after Antigen Specific Triggering of Introduced TCRs under Control of a Retroviral Promotor.

Marleen M. van Loenen, Renate S. Hagedoorn, Esther H.M. van Egmond, Roel Willemze, MD, PhD, J.H.Frederik Falkenburg, MD, PhD, Mirjam H.M. Heemskerk, PhD
Journal: Blood
Blood (2005) 106 (11): 5537.
https://doi.org/10.1182/blood.V106.11.5537.5537
Published: 2005
Journal Articles

Re-Engineering γ δ T Cells by α β T Cell Receptor Gene Transfer Creates Potent Effector Cells with Anti-Leukemic Reactivity.

Lars T. van der Veken, Renate S. Hagedoorn, Marleen M. van Loenen, Roel Willemze, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk
Journal: Blood
Blood (2005) 106 (11): 1288.
https://doi.org/10.1182/blood.V106.11.1288.1288
Published: 2005